Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Apr;119(4):768-71.
doi: 10.1172/jci38786.

Kallikreins and lupus nephritis

Affiliations
Comment

Kallikreins and lupus nephritis

Claudio Ponticelli et al. J Clin Invest. 2009 Apr.

Abstract

The kidney kallikrein-kinin system plays important roles in inflammation, coagulation, angiogenesis, and regulation of vessel tone and permeability. In this issue of the JCI, Liu et al. provide data that suggest a protective role for kallikrein in animal models of anti-glomerular basement membrane(GBM) antibody-induced nephritis, an experimental model of Goodpasture disease (see the related article beginning on page 911). Furthermore, human systemic lupus erythematosus and lupus nephritis were shown to be associated with kallikrein 1 (KLK1) and the KLK3 promoter. The authors suggest that kallikrein genes are involved in the development of SLE and lupus nephritis and may exert a renoprotective role. It is possible, however, that the kallikrein-kinin system may play dual roles: protecting the kidney against ischemia and interstitial fibrosis while also mediating vasodilation, inflammation, and activation of the innate immune response.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Simplified overview of the kallikrein-kinin system.
Kallikreins originate from prekallikrein, which is cleaved to form kallikrein after being activated by factor XIIa (Hageman factor). Kallikreins are enzymes that cleave kininogens (proteins derived mainly from α2-globulins) into peptides called kinins. In turn, kinins may be cleaved by kininases to form inactive final products or may bind to their receptors and exert pharmacological activity.
Figure 2
Figure 2. The main mechanisms mediating kidney damage in lupus nephritis.
SLE is characterized by an accumulation of apoptotic material due to its poor clearance (9) (i). This leads to an immune response against chromatin (ii) and to increased expression and binding of apoptotic-chromatin antigens to kidney glomerular structures (iii). Antibodies against apoptotic-chromatin antigens (in particular anti-dsDNA and anti-nucleosome antibodies) may form immune complexes in the kidney with their specific planted antigens or may be entrapped on glomerular structures as immune complexes preformed in the circulation (iv). Immune complex deposition/formation eventually leads to immune-mediated tissue inflammation and damage (v). Local factors may also increase the susceptibility of renal tissue to damage (vi): Chromatin antigens may accumulate in the kidney tissue because of reduced DNAse-mediated chromatin degradation (11), and immune-mediated inflammation may itself increase vessel permeability, consequently increasing diffusion of the autoantigens themselves and of the soluble and cellular mediators of the autoimmune response. In this context, the lack of the potentially protective effect of kinins may represent an additional mechanism contributing to renal tissue damage. Ag, antigen.

Comment on

  • Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.
    Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramón E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA; Profile Study Group; Italian Collaborative Group; German Collaborative Group; Spanish Collaborative Group; Argentinian Collaborative Group; SLEGEN Consortium; Wakeland EK, Alarcón-Riquelme ME, Mohan C. Liu K, et al. J Clin Invest. 2009 Apr;119(4):911-23. doi: 10.1172/JCI36728. J Clin Invest. 2009. PMID: 19307730 Free PMC article.

References

    1. Evans B.A., et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry. 1988;27:3124–3129. doi: 10.1021/bi00409a003. - DOI - PubMed
    1. Riegman P.H., et al. The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett. 1989;247:123–126. doi: 10.1016/0014-5793(89)81253-0. - DOI - PubMed
    1. Bossi F., Bulla R., Tedesco F. Endothelial cells are a target of both complement and kinin system. Int. Immunopharmacol. . 2008;8:143–147. doi: 10.1016/j.intimp.2007.08.006. - DOI - PubMed
    1. Song Q., Chao J., Chao L. High level expression of human tissue kallikrein in the circulation induces hypotension in transgenic mice. Immunopharmacology. 1996;32:105–107. doi: 10.1016/0162-3109(95)00065-8. - DOI - PubMed
    1. Margolius H.S., Horwitz D., Pisano J.J., Keiser H.R. Urinary kallikrein excretion in hypertensive man. Relationship to sodium intake and sodium-retaining steroids. Circ. Res. 1974;35:820–825. - PubMed